Last edition
News about "AstraZeneca Pharma India gets CDSCO approval for t"
AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country
According to World Health Organisation, more than four lakh cases of endometrial cancer were diagnosed in 2022 with >17,000 cases newly detected in India. The incidence of endometrial cancer is projected to increase by >20% globally and in India.<br />
AstraZeneca Pharma India Gets CDSCO Approval For T | 02/07/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members